The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease

被引：6
|
作者：
Pineles, David [1 ]
Malter, Lisa [2 ]
Liang, Peter S. [3 ]
Arsuaga, Amy [4 ]
Bosworth, Brian [1 ,4 ]
Hudesman, David P. [4 ]
Chang, Shannon [4 ]
机构：
[1] NYU Langone Hlth, Dept Med, New York, NY USA
[2] Bellevue Hosp, Div Gastroenterol, New York, NY USA
[3] Manhattan Med Ctr, VA New York Harbor Healthcare Syst, Div Gastroenterol, New York, NY USA
[4] NYU Langone Hlth, Div Gastroenterol, Inflammatory Bowel Dis Ctr, New York, NY 10016 USA
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 74卷 / 10期
关键词：
D O I：
10.1007/s00228-018-2492-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1361 / 1362
页数：2
相关论文
共 50 条
  • [31] Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation
    Ben-Horin, Shomron
    Vande Casteele, Niels
    Schreiber, Stefan
    Lakatos, Peter Laszlo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (12) : 1685 - 1696
  • [32] Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence
    McConachie, Sean
    Wilhelm, Sheila M.
    Kale-Pradhan, Pramodini B.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (04) : 391 - 400
  • [33] The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease
    Patil, Seema A.
    Bhat, Shubha
    Limdi, Jimmy K.
    Farraye, Francis A.
    Cross, Raymond K.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (12) : 1915 - 1923
  • [34] Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
    Argollo, Marjorie
    Fiorino, Gionata
    Gilardi, Daniela
    Furfaro, Federica
    Roda, Giulia
    Loy, Laura
    Allocca, Mariangela
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (01) : 7 - 12
  • [35] Biosimilars in inflammatory bowel disease: ready for prime time?
    Gomollon, Fernando
    CURRENT OPINION IN GASTROENTEROLOGY, 2015, 31 (04) : 290 - 295
  • [36] The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease
    Severs, M.
    Oldenburg, B.
    van Bodegraven, A. A.
    Siersema, P. D.
    Mangen, M-J. J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (03): : 289 - 296
  • [37] Position statement on the use of biosimilars in inflammatory bowel disease
    Emanuel, Burri
    Pascal, Juillerat
    Michel, Maillard H.
    Michael, Manz
    Pierre, Michetti
    Christian, Mottet
    Gerhard, Rogler
    Nadine, Zahnd
    Stephan, Vavricka
    SWISS MEDICAL WEEKLY, 2019, 149
  • [38] Insights on the use of biosimilars in the treatment of inflammatory bowel disease
    Zheng, Michael K.
    Shih, David Q.
    Chen, Gary C.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (11) : 1932 - 1943
  • [39] Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
    Ali Hakizimana
    Iftikhar Ahmed
    Rachel Russell
    Mark Wright
    Nadeem A Afzal
    World Journal of Gastroenterology, 2017, (25) : 4473 - 4479
  • [40] Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
    Hakizimana, Ali
    Ahmed, Iftikhar
    Russell, Rachel
    Wright, Mark
    Afzal, Nadeem A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (25) : 4473 - 4479
12345